RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • SCOPUSKCI등재

        小細胞未分化肺癌의 放射線治療

        조문준(M.J. Cho),하성환(S.W.Ha),박찬일(C.I.Pack),김락경(N.K.Kim) 대한방사선종양학회 1984 Radiation Oncology Journal Vol.2 No.2

        The recogition that the vast majority of patients with small cell lung cancer have distant metastatic disease at the time of diagnosis lead to the use of systemic chemotherapy and consequent major improvement in survival, but recently evaulated treatment strategies, integration of large field chest irradiation with chemotherapy lead to the improved the local control and relapse free survival in limited SCLC. Therefore, it is logical to combine the two modalities in an effort to maximize the therapeutic effect. Authors performed the combination chemotherapy of CAV(Cyclophosphamide, Adriamycin, and Vincristine) and radiotherapy of primary tumor and regional lymphatics with prophylatic cranial irradiation in 42 patients of limited SCLC, from MAR. 1978 to Dec. 1982 Seoul National University Hospital. The results are as follows; 1. CR and PR after 2 cycles chemotherapy is 7% and 43%, respectively however, subsequent response to radiotherapy is 38% and 43% in CR and PR. 2. Overall median survival period is 8.6 months. 3. 1 year and 2 year survival rate is 46.3% and 20.5%, respectively. 4. Incidence of proven brain metastasis is 5%.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼